139 related articles for article (PubMed ID: 30087419)
1. Germline duplication of ATG2B and GSKIP genes is not required for the familial myeloid malignancy syndrome associated with the duplication of chromosome 14q32.
Babushok DV; Stanley NL; Morrissette JJD; Lieberman DB; Olson TS; Chou ST; Hexner EO
Leukemia; 2018 Dec; 32(12):2720-2723. PubMed ID: 30087419
[No Abstract] [Full Text] [Related]
2. Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.
Saliba J; Saint-Martin C; Di Stefano A; Lenglet G; Marty C; Keren B; Pasquier F; Valle VD; Secardin L; Leroy G; Mahfoudhi E; Grosjean S; Droin N; Diop M; Dessen P; Charrier S; Palazzo A; Merlevede J; Meniane JC; Delaunay-Darivon C; Fuseau P; Isnard F; Casadevall N; Solary E; Debili N; Bernard OA; Raslova H; Najman A; Vainchenker W; Bellanné-Chantelot C; Plo I
Nat Genet; 2015 Oct; 47(10):1131-40. PubMed ID: 26280900
[TBL] [Abstract][Full Text] [Related]
3. Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms.
Pegliasco J; Hirsch P; Marzac C; Isnard F; Meniane JC; Deswarte C; Pellet P; Lemaitre C; Leroy G; Rabadan Moraes G; Guermouche H; Schmaltz-Panneau B; Pasquier F; Colas C; Benusiglio PR; Bera O; Bourhis JH; Brissot E; Caron O; Chraibi S; Cony-Makhoul P; Delaunay-Darivon C; Lapusan S; de Fontbrune FS; Fuseau P; Najman A; Vainchenker W; Delhommeau F; Micol JB; Plo I; Bellanné-Chantelot C
Leukemia; 2022 Jan; 36(1):126-137. PubMed ID: 34172895
[TBL] [Abstract][Full Text] [Related]
4.
Pegliasco J; Schmaltz-Panneau B; Martin JE; Chraibi S; Khalife-Hachem S; Salviat F; Pasquier F; Willekens C; Lopez M; Ben-Ali A; Bera O; Caron O; Castilla-Llorent C; Cotteret S; Bourdin C; Saada V; Auger N; de Botton S; Vainchenker W; Fuseau P; Helias P; Benabdelali R; Marzac C; Meniane JC; Plo I; Bellanné-Chantelot C; Micol JB
Leuk Lymphoma; 2021 Jul; 62(7):1770-1773. PubMed ID: 33554699
[No Abstract] [Full Text] [Related]
5. Loss of
Sakai SS; Hasegawa A; Ishimura R; Tamura N; Kageyama S; Komatsu-Hirota S; Abe M; Ling Y; Okuda S; Funayama M; Kikkawa M; Miura Y; Sakimura K; Narita I; Waguri S; Shimizu R; Komatsu M
Mol Cell Biol; 2022 Jan; 42(1):e0002421. PubMed ID: 34748402
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia].
Király PA; Kállay K; Marosvári D; Benyó G; Szőke A; Csomor J; Bödör C
Orv Hetil; 2016 Feb; 157(8):283-9. PubMed ID: 26876264
[TBL] [Abstract][Full Text] [Related]
7. Germline heterozygous DDX41 variants in a subset of familial myelodysplasia and acute myeloid leukemia.
Cardoso SR; Ryan G; Walne AJ; Ellison A; Lowe R; Tummala H; Rio-Machin A; Collopy L; Al Seraihi A; Wallis Y; Page P; Akiki S; Fitzgibbon J; Vulliamy T; Dokal I
Leukemia; 2016 Oct; 30(10):2083-2086. PubMed ID: 27133828
[No Abstract] [Full Text] [Related]
8. ATG2B and GSKIP: 2 new genes predisposing to myeloid malignancies.
Plo I; Bellanné-Chantelot C; Vainchenker W
Mol Cell Oncol; 2016 Mar; 3(2):e1094564. PubMed ID: 27308616
[TBL] [Abstract][Full Text] [Related]
9. Myeloid Neoplasms with Germline Predisposition: A New Provisional Entity Within the World Health Organization Classification.
Czuchlewski DR; Peterson LC
Surg Pathol Clin; 2016 Mar; 9(1):165-76. PubMed ID: 26940275
[TBL] [Abstract][Full Text] [Related]
10. Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary.
Király AP; Kállay K; Gángó A; Kellner Á; Egyed M; Szőke A; Kiss R; Vályi-Nagy I; Csomor J; Matolcsy A; Bödör C
Pathol Oncol Res; 2018 Jan; 24(1):83-88. PubMed ID: 28357685
[TBL] [Abstract][Full Text] [Related]
11. Familial myelodysplasia and acute myeloid leukaemia--a review.
Owen C; Barnett M; Fitzgibbon J
Br J Haematol; 2008 Jan; 140(2):123-32. PubMed ID: 18173751
[TBL] [Abstract][Full Text] [Related]
12. Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?
Tawana K; Drazer MW; Churpek JE
Leukemia; 2018 Jul; 32(7):1482-1492. PubMed ID: 29483711
[TBL] [Abstract][Full Text] [Related]
13. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Nardi V; Hasserjian RP
Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
[TBL] [Abstract][Full Text] [Related]
14. Integrating germline variant assessment into routine clinical practice for myelodysplastic syndrome and acute myeloid leukaemia: current strategies and challenges.
Tawana K; Brown AL; Churpek JE
Br J Haematol; 2022 Mar; 196(6):1293-1310. PubMed ID: 34658019
[TBL] [Abstract][Full Text] [Related]
15. Involvement of both chromosomes 5 in a patient with leukemia secondary to myelodysplastic syndrome.
Berkowicz M; Rechavi G; Rosner E; Ben-Bassat I; Ramot B
Cancer Genet Cytogenet; 1990 Sep; 48(2):279-80. PubMed ID: 2397460
[No Abstract] [Full Text] [Related]
16. Any role for the nucleophosmin (NPM1) gene in myelodysplastic syndromes and acute myeloid leukemia with chromosome 5 abnormalities?
Falini B
Leuk Lymphoma; 2007 Nov; 48(11):2093-5. PubMed ID: 17990174
[No Abstract] [Full Text] [Related]
17. Myelodysplastic syndromes and acute leukemia with genetic predispositions: a new challenge for hematologists.
Duployez N; Lejeune S; Renneville A; Preudhomme C
Expert Rev Hematol; 2016 Dec; 9(12):1189-1202. PubMed ID: 27819178
[TBL] [Abstract][Full Text] [Related]
18. Familial myelodysplastic syndrome/acute myeloid leukemia.
Churpek JE
Best Pract Res Clin Haematol; 2017 Dec; 30(4):287-289. PubMed ID: 29156196
[TBL] [Abstract][Full Text] [Related]
19. Translocation (8;21)(q22;q22) and the myelodysplastic syndrome.
Kwong YL; Wong KF
Leuk Res; 1995 Sep; 19(9):675-7. PubMed ID: 7564479
[No Abstract] [Full Text] [Related]
20. Myeloid neoplasms with germline DDX41 mutation.
Cheah JJC; Hahn CN; Hiwase DK; Scott HS; Brown AL
Int J Hematol; 2017 Aug; 106(2):163-174. PubMed ID: 28547672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
